geoopen
A neoadjuvant, phase II trial demonstrates efficacy and tolerability of Talimogene laherparepvec in cutaneous basal cell carcinoma (NeoBCC trial)
GEO Series GSE268728. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
ShareScore
24/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 8
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8